Amedisys/ US0234361089 /
14/06/2024 21:59:58 | Diferencia +0.13 | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
91.79USD | +0.14% | 4,845 Volumen de negocios: 443,336.38 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 3 mil millonesUSD | - | - |
GlobeNewswire
1:16
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
15/06
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Humana Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
15/06
ROSEN, A LEADING LAW FIRM, Encourages FAT Brands Inc. Investors to Secure Counsel Before Important D...
GlobeNewswire
15/06
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Intel Corporation Investors to Secure Counsel Befor...
GlobeNewswire
15/06
ROSEN, A LEADING NATIONAL FIRM, Encourages Harbor Diversified, Inc. Investors to Secure Counsel Befo...
Newsfile Corp
15/06
ROSEN, A TOP RANKED LAW FIRM, Encourages Autodesk, Inc. Investors to Secure Counsel Before Important...
Newsfile Corp
15/06
TOP RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important De...
Newsfile Corp
15/06
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Bef...
GlobeNewswire
15/06
GDRX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página